The report "Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) - Global Forecast to 2025" The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.
Browse 153 market data Tables and 45 Figures spread through 227 Pages and in-depth TOC on "Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) - Global Forecast to 2025"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/global-transplant-diagnostics-market-2531061.html
The demand for transplant diagnostic products is expected to grow mainly due to factors such as technological advancements, the growing number of diagnostic centers & hospitals, increased applications in patient profiling, and rising public-private investments to support product development. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities-especially in emerging markets, which are expected to witness the highest growth.
Based on product, the reagents & consumables segment held the largest share of the market in 2019.
On the basis of product, the transplant diagnostics market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of the global transplant diagnostics market in 2019. Factors such as the increasing patient emphasis on effective and early patient profiling during organ transplantation and the growing adoption of transplant diagnostic techniques in related research studies are driving the growth of this segment.
Based on technology, the molecular assays segment is expected to witness the highest growth during the forecast period.
On the basis of technology, the transplant diagnostics market is segmented into molecular assay and non-molecular assay technology. The molecular assay technology segment is expected to register the highest CAGR during the forecast period. Factors such as its varied applications in patient profiling, rising public-private investments to support product development, and increasing clinical evidence of its efficacy are driving the growth of this segment.
Based on the transplant type, the solid organ transplantation segment accounted for the largest share of this market in 2019.
On the basis of transplant type, the transplant diagnostics market is categorized into solid organ, stem cell, and soft tissue transplantation. Solid organ transplantation accounted for the largest share of the transplant diagnostics market in 2019. Supportive government regulations to increase organ donations across major healthcare markets, the rising number of chronic diseases/disorders leading to transplantation, and ongoing technological advancements in the field of transplant diagnostics are the key factors supporting the growth of the market for solid organ transplantation.
North America accounted for the largest share of the transplant diagnostics market in 2019
North America accounted for the largest share of the transplant diagnostics market in 2019, followed by Europe. This can primarily be attributed to the continuous commercialization of innovative transplant diagnostic products coupled with ongoing advancements in the field of genomics and proteomics, recent discovery genetic biomarkers & their clinical role in immunoassay testing, and the increasing prevalence of chronic and communicable diseases.
Some of the prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (US), and bioMérieux S.A. (France). Others are Immucor, Inc. (US), Illumina, Inc. (US), Luminex Corporation (US), CareDx (US), Becton, Dickinson and Company (US), Hologic (US), and GenDx (Netherlands).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441